Incidence and outcomes of malignancies in renal transplant recipients: a 57-year single-center experience
World Journal of Urology · 21.01.2026 · 44 (1)
DOI: 10.1007/s00345-025-06128-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, online erschienen am 21.01.2026. Verfasst von Librado Jonas Baños-Peña und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Belisario Dominguez Secc. 16, 14080,…. Hauptthemen laut MEDLINE: Kidney Transplantation, Postoperative Complications, Neoplasms, Urogenital Neoplasms. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Kidney transplant recipients (KTRs) have a markedly increased risk of malignancy due to chronic immunosuppression and oncogenic exposures. This study describes the spectrum, management, and outcomes of post-transplant malignancies over nearly six decades at a tertiary center. METHODS: We conducted a retrospective study of adult KTRs at the National Institute of Nutrition (1967–2024). Patients with post-transplant malignancy and complete clinical records were included. Demographic data, immunosuppressive regimens, tumor characteristics, treatment, and survival were analyzed. Tumor-level and patient-level denominators were reported separately. RESULTS: Among 1,419 KTRs, 116 developed cancer and 98 had complete records, accounting for 136 malignancies. Per tumor, non-melanoma skin cancer represented 41% (56/136), genitourinary (GU) cancers 27% (37/136), and lymphomas 12% (16/136). At the patient level, 61% were male and 51% were older than 50 years at diagnosis. Three EBV-positive post-transplant lymphoproliferative disorders were identified. Most tumors were localized (86%) and surgically treated (84%). Median overall survival after cancer diagnosis was 19.0 years (1-, 3-, and 5-year survival: 0.90, 0.84, and 0.82), while cancer-specific and disease-free survival did not reach median (5-year: 0.96 and 0.88). On multivariable analysis, mycophenolate mofetil (MMF) use was independently associated with a GU malignancy phenotype (OR 4.79; 95% CI 1.11–20.70). Age > 50 years was associated with worse overall survival on log-rank testing. CONCLUSIONS: In this long-term cohort, non-melanoma skin and GU cancers were the most common post-transplant malignancies. Most tumors were detected at localized stages, yet older age and immunosuppressive exposure influenced cancer phenotype and prognosis. EBV-related PTLD was documented. These findings support tailored oncologic surveillance —emphasizing dermatologic evaluation, renal imaging of native and graft kidneys, risk-adapted PSA testing— and careful immunosuppression modulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Belisario Dominguez Secc. 16, 14080, Mexico City, Mexico.
- Department of Nephrology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Department of Urology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Belisario Dominguez Secc. 16, 14080, Mexico City, Mexico. ricardo.castillejosm@incmnsz.mx.
Zitieren
APA
Baños-Peña, L. J., Lagos-Beitz, H. E., Aguirre-Anaya, L. I., Marino-Vazquez, L. A., Tena Gonzalez-Mendez, G., Gabilondo-Pliego, B., & Castillejos-Molina, R. A. (2026). Incidence and outcomes of malignancies in renal transplant recipients: a 57-year single-center experience. World Journal of Urology, 44(1). https://doi.org/10.1007/s00345-025-06128-9
Vancouver
Baños-Peña LJ, Lagos-Beitz HE, Aguirre-Anaya LI, Marino-Vazquez LA, Tena Gonzalez-Mendez G, Gabilondo-Pliego B, et al. Incidence and outcomes of malignancies in renal transplant recipients: a 57-year single-center experience. World Journal of Urology. 2026;44(1). doi:10.1007/s00345-025-06128-9
BibTeX
@article{BaosPea2026,
author = {Baños-Peña, Librado Jonas and Lagos-Beitz, Horst Emanuel and Aguirre-Anaya, Luis Iván and Marino-Vazquez, Lluvia A and Tena Gonzalez-Mendez, Gerardo and Gabilondo-Pliego, Bernardo and Castillejos-Molina, Ricardo Alonso},
title = {Incidence and outcomes of malignancies in renal transplant recipients: a 57-year single-center experience},
journal = {World Journal of Urology},
year = {2026},
volume = {44},
number = {1},
doi = {10.1007/s00345-025-06128-9}
}
EUVIMED